Advertisement

Topics

NewLink Genetics Announces FDA Orphan-Drug Designation for Indoximod

00:11 EDT 30 Oct 2017 | Drugs.com

AMES, Iowa, Oct. 30, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that indoximod, its leading drug development candidate, was granted orphan-drug designation by the U.S. Food and Drug Administration (FDA) for...

Original Article: NewLink Genetics Announces FDA Orphan-Drug Designation for Indoximod

NEXT ARTICLE

More From BioPortfolio on "NewLink Genetics Announces FDA Orphan-Drug Designation for Indoximod"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...